Hervana Overview

  • Founded
  • 2008
Founded
  • Status
  • Private
  • Employees
  • 3
Employees
  • Latest Deal Type
  • Grant
  • Latest Deal Amount
  • $997K
Latest Deal Amount
  • Investors
  • 1

Hervana General Information

Description

Developer of female non-hormonal contraceptives. The company develops a sperm motility-inhibiting probiotic agent which prevents fertilization and also protects against sexually transmitted diseases.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Angel-Backed
Primary Industry
Biotechnology
Primary Office
  • Naftali 9/8
  • Jerusalem
  • Israel
+972 000-000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Hervana Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Grant 04-Jun-2012 $997K Completed Startup
2. Grant 01-May-2010 00000 Completed Startup
1. Angel (individual) Completed Startup
To view Hervana’s complete valuation and funding history, request access »

Hervana Executive Team (3)

Name Title Board Seat Contact Info
Rachel Teitelbaum Ph.D Founder & Co-Chief Executive Officer
David Zakai Chief Operating Officer, Vice President, Business Development & Chief Business Officer
You’re viewing 2 of 3 executive team members. Get the full list »

Hervana Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Hervana Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Bill & Melinda Gates Foundation Not-For-Profit Venture Capital Minority 000 0000 000000 0
To view Hervana’s complete investors history, request access »